Dekorationsartikel gehören nicht zum Leistungsumfang.
Sprache:
Englisch
77,70 €
Versandkostenfrei per Post / DHL
Lieferzeit 1-2 Wochen
Kategorien:
Beschreibung
"Transcranial magnetic stimulation (TMS) is a noninvasive method to stimulate the human brain, modulating brain activity without surgery or anesthesia. TMS uses a brief, high-intensity, pulsed magnetic field, which induces an electrical field capable of depolarizing a localized brain area. In October 2008, the first TMS system was cleared by the FDA to treat adult patients with major depressive disorder (MDD) who have not responded to one antidepressant medication. Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice, 2nd Edition, is a practical reference for managing patients who are candidates for TMS. Since publication of the first edition, devices have received FDA clearance for obsessive-compulsive disorder, anxiety comorbid with MDD, and smoking cessation, and insurance coverage for TMS has expanded. The book discusses the integration of TMS with psychotherapy, pharmacotherapy, and other forms of neuromodulation; the identification of appropriate patients for referral to a TMS clinician; coordination of care to ensure the best outcomes during the acute, continuation, and maintenance treatment phases of depression; and the evolving nature of TMS research. The volume appendix lists various options for advanced TMS training"--
"Transcranial magnetic stimulation (TMS) is a noninvasive method to stimulate the human brain, modulating brain activity without surgery or anesthesia. TMS uses a brief, high-intensity, pulsed magnetic field, which induces an electrical field capable of depolarizing a localized brain area. In October 2008, the first TMS system was cleared by the FDA to treat adult patients with major depressive disorder (MDD) who have not responded to one antidepressant medication. Transcranial Magnetic Stimulation: Clinical Applications for Psychiatric Practice, 2nd Edition, is a practical reference for managing patients who are candidates for TMS. Since publication of the first edition, devices have received FDA clearance for obsessive-compulsive disorder, anxiety comorbid with MDD, and smoking cessation, and insurance coverage for TMS has expanded. The book discusses the integration of TMS with psychotherapy, pharmacotherapy, and other forms of neuromodulation; the identification of appropriate patients for referral to a TMS clinician; coordination of care to ensure the best outcomes during the acute, continuation, and maintenance treatment phases of depression; and the evolving nature of TMS research. The volume appendix lists various options for advanced TMS training"--
Details
Erscheinungsjahr: | 2025 |
---|---|
Fachbereich: | Andere Fachgebiete |
Genre: | Importe, Medizin |
Rubrik: | Wissenschaften |
Medium: | Taschenbuch |
Inhalt: | Einband - flex.(Paperback) |
ISBN-13: | 9798894550657 |
Sprache: | Englisch |
Einband: | Kartoniert / Broschiert |
Autor: |
Richard A. Bermudes
Karl Lanocha Philip G. Janicak |
Redaktion: |
Lanocha, Karl
Janicak, Philip G. Bermudes, Richard A. |
Auflage: | Second Edition |
Hersteller: | American Psychiatric Association Publishing |
Verantwortliche Person für die EU: | Libri GmbH, Europaallee 1, D-36244 Bad Hersfeld, gpsr@libri.de |
Maße: | 234 x 153 x 21 mm |
Von/Mit: | Karl Lanocha (u. a.) |
Erscheinungsdatum: | 28.02.2025 |
Gewicht: | 0,542 kg |